MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson’s disease

    KJ. Pak, HK. Shin, EJ. Kim, JH. Lee, CH. Lyoo, JS. Son, MJ. Lee, HJ. Son (Busan, Republic of Korea)

    Objective: To investigate whether weight loss has a longitudinal association with striatal dopaminergic degeneration in Parkinson's disease (PD). Background: Weight loss in PD is associated…
  • 2018 International Congress

    No differences in the total burden of non-motor symptoms between Parkinson’s disease and non-degenerative parkinsonism

    E. Jaakkola, J. Joutsa, E. Mäkinen, T. Noponen, M. Pitkonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To compare the total burden of non-motor symptoms between Parkinson's disease and non-degenerative parkinsonism and to study the possible dopaminergic background of these symptoms.…
  • 2018 International Congress

    Stigma and communication in people with Parkinson’s disease (PPD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: To present results about stigma in PPD from a Parkinson’s Workshop. These are preliminary results in the path to address the main project question…
  • 2018 International Congress

    Freezing of gait recognition in Parkinson’s disease: A subject independent objective method

    V. Rama Raju (Hyderabad, India)

    Objective: In this study, we aim to build an automated-FoG-detector for subject-independent. After extracting enormously relevant features, we apply variance detection-techniques to identify-FoG-events. Background: Gait…
  • 2018 International Congress

    Profiles of microRNA in cerebrospinal fluid could be potential biomarkers for identifying motor subtype of Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: We investigated CSF miRNA expression in PD and control subjects. We also evaluated if specific miRNA were differently expressed according to motor subtype of…
  • 2018 International Congress

    Cell and animal models lacking RAB39B show biochemical and behavioural phenotypes that model aspects of Parkinson’s disease

    Y. Gao, G. Wilson, S. Stephenson, K. Bozaoglu, M. Dottori, P. Thomas, P. Lockhart (Melbourne, Australia)

    Objective: To determine the pathogenic mechanisms underlying RAB39B-mediated Parkinson’s disease (PD). Background: PD is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the…
  • 2018 International Congress

    Determination of falling direction in Parkinson’s disease patients using a wearable sensor

    Y. Okuma, H. Mitoma (Izunokuni, Japan)

    Objective: The aim of this study is to objectively detect falls and their direction in Parkinson’s disease (PD) patients during everyday activities. Background: Falling is…
  • 2018 International Congress

    Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson’s disease

    Y. Qian, X. Yang, S. Xu, Q. Xiao (Shanghai, China)

    Objective: To explore the effects of probiotics strains on the neuroinflammation and degeneration of dopaminergic neurons in chronic Parkinson’s disease (PD) mice model. Background: Microglia-mediated…
  • 2018 International Congress

    Speech intelligibility and comprehensibility in Slovak patients with Parkinson’s disease

    A. Kušnírová, Ľ. Mičianová, Z. Košutzká, I. Straka, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our study was to evaluate intelligibility and comprehensibility (intelligibility in context) and its relationship with MDS-UPDRS (sub)scores in Slovak population of…
  • 2018 International Congress

    α-synuclein antibody 5G4 identifies manifest and prodromal Parkinson’s disease in colonic mucosa

    M. Skorvanek, E. Gelpi, E. Mechirova, Z. Ladomirjakova, V. Han, N. Lesko, E. Feketeova, J. Ribeiro Ventosa, F. Kudela, K. Kulcsarova, S. Babinska, S. Toth, L. Gombosova, F. Trebuna, M. Lutz, Z. Gdovinova, G. Kovacs (Kosice, Slovakia)

    Objective: The aim of this study was to evaluate colonic mucosa staining using the 5G4 antibody, specific only for the disease-associated form of α-synuclein, in…
  • « Previous Page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley